Releuko Filgrastim Ayow — Carefirst Caremark
20 indications indexed for this drug.
- Acute Myeloid LeukemiaView coverage criteria
- Agranulocytosis Non Chemotherapy Drug InducedView coverage criteria
- Aplastic AnemiaView coverage criteria
- Chronic Myeloid Leukemia Treatment Of Persistent NeutropeniaView coverage criteria
- Glycogen Storage Disease Gsd Type 1View coverage criteria
- Hairy Cell Leukemia Neutropenic FeverView coverage criteria
- Neutropenia In Cancer Patients Receiving Myelosuppressive ChView coverage criteria
- Neutropenia Related To Hiv AidsView coverage criteria
- Neutropenia Related To Renal TransplantationView coverage criteria
- Patients Acutely Exposed To Myelosuppressive Doses Of RadiatView coverage criteria
- Patients Undergoing Autologous Peripheral Blood Progenitor CView coverage criteria
- Patients With Acute Myeloid Leukemia Receiving Induction OrView coverage criteria
- Patients With Cancer Undergoing Bone Marrow TransplantationView coverage criteria
- Patients With Severe Chronic NeutropeniaView coverage criteria
- Primary Prophylaxis Of Febrile Neutropenia In Members With SView coverage criteria
- Prophylaxis For Chemotherapy Induced Febrile Neutropenia InView coverage criteria
- Supportive Care For Neutropenic Patients With Car T Cell RelView coverage criteria
- Treatment Of Anemia And Neutropenia In Patients With MyelodyView coverage criteria
- Treatment Of Chemotherapy Induced Febrile NeutropeniaView coverage criteria
- Treatment Of High Risk Febrile Neutropenia In Members With PView coverage criteria